April 4 (Reuters) - Athersys Inc ATHX.O :
* ATHERSYS REPORTS THAT ITS PARTNER, HEALIOS K.K., PROVIDES
UPDATES ON MULTISTEM® CLINICAL PROGRAMS IN JAPAN
* ATHERSYS INC - LAST 365-DAY PATIENT FOLLOW-UP VISIT WAS
COMPLETED ON SCHEDULE FOR PHASE 2/3 TREASURE STUDY FOR ISCHEMIC
STROKE
* ATHERSYS REPORTS THAT ITS PARTNER, HEALIOS K.K., PROVIDES
UPDATES ON MULTISTEM® CLINICAL PROGRAMS IN JAPAN
* ATHERSYS INC - TOPLINE RESULTS EXPECTED TO BE ANNOUNCED IN
MAY
* ATHERSYS INC - HEALIOS ANTICIPATES THAT IT WILL RECEIVE
FINAL
TOPLINE RESULTS AND MAKE DISCLOSURES IN MAY 2022
Source text for Eikon: ID:nBwb6V7n3a
Further company coverage: ATHX.O
((Reuters.Briefs@thomsonreuters.com;))